Lesson 1Evidence limits and uncertainty: interpreting low-quality/biased studies and clinician communication with patientsE discuss limits of anabolic research, like pick bias, under-report, and mix-up. E teach doctors to read weak or clash data, yarn uncertainty, and help patient make informed choices based on wetin dem value.
Common biases in anabolic researchInterpreting observational and case dataHandling conflicting or absent evidenceExplaining uncertainty to patientsShared decision-making under ambiguityDocumenting risk discussions clearlyLesson 2Acute and subacute adverse effects: polycythemia, hypertension, acne, mood/behavior changes, hepatic injury (oral agents), injection complicationsE outline common early bad effects from anabolic, like too much blood cells, high blood pressure, pimples, mood change, liver hurt from oral ones, and jab problems. E give practical steps for find, grade, and handle.
Polycythemia detection and managementBlood pressure elevation and treatmentDermatologic effects and acne careHepatic injury from oral agentsInjection-site and infectious issuesWhen acute effects require cessationLesson 3Cardiovascular risks: dyslipidemia, myocardial hypertrophy, thrombosis, arrhythmia risk and available evidenceE explore how anabolic affect fats, pressure, heart muscle, and clotting. E review human and animal data on artery block, heart rhythm issues, sudden death, and how to grade and cut heart risk for users.
Mechanisms of dyslipidemia and hypertensionMyocardial hypertrophy and remodelingThrombosis and coagulation abnormalitiesArrhythmias and sudden cardiac death riskImaging and functional cardiac assessmentRisk stratification and mitigation stepsLesson 4Psychiatric and neurobehavioral effects: aggression, mood disorders, dependence, and withdrawal syndromesE cover aggression, bad temper, down mood, worry, and suicide link wid anabolic. E detail addiction, must-cycle, and stop syndromes, plus check, safety plan, and send to mind health service.
Aggression, irritability, and violence riskMood disorders and suicidalityCognitive and impulse-control changesDependence, craving, and compulsive useWithdrawal syndromes and taperingCollaboration with mental health servicesLesson 5Harm reduction principles when non-medical use is disclosed: minimizing acute harms, infection prevention, safer dosing concepts, and when to refuse to prescribeE apply harm cut when non-med use come out, focus no-judgment talk, safer dose ideas, infection stop, and real goals. E clear legal, right, and clinic limits for no prescribe.
Nonjudgmental assessment and rapportSafer dosing and cycle design conceptsInjection hygiene and infection preventionOverdose and acute crisis planningWhen to decline prescribing or supportReferral pathways and community resourcesLesson 6Ongoing monitoring protocols: frequency and thresholds for intervention, red flags for urgent cessation and referralE define follow-up for anabolic users, including visit time, lab and scan gaps, and levels wey start dose change, stop, or send. E stress see red flags and write shared choices.
Visit frequency by risk categoryRoutine lab and imaging intervalsAction thresholds for key lab changesClinical signs requiring urgent cessationCriteria for specialist referralDocumentation and follow-up planningLesson 7Reproductive and endocrine sequelae: hypogonadism, testicular atrophy, infertility, menstrual disturbances, virilization in femalesE review how anabolic mess brain-gland-testicle line, cause low hormone, small balls, no seed, period mess, and man-features for women. E address check, counsel, and heal hopes.
HPG axis suppression mechanismsMale hypogonadism and testicular atrophyMale and female fertility impairmentMenstrual disruption in female usersVirilization signs and reversibilityEndocrine recovery and PCT limitsLesson 8Musculoskeletal and metabolic harms: tendon injury risk, insulin resistance, and body composition changes over timeE check muscle-bone and body fuel harms, like tendon hurt, change collagen, insulin block, sugar mess, and long body shape change. E describe screen, counsel on train load, and risk cut ways.
Tendon structure and rupture riskJoint stress and injury patternsInsulin resistance and glucose controlVisceral fat and body composition shiftsScreening for metabolic syndromeTraining and rehab modificationsLesson 9Screening and baseline evaluation to mitigate risk: CBC, CMP/LFTs, lipid panel, testosterone/hormone profile, PSA, ECG, blood pressure and targeted imaging when indicatedE detail start history, body check, and target tests before or during anabolic. E explain how blood count, liver/kidney, fats, hormones, PSA, heart trace, pressure, and scans guide risk grade and personal monitor plans.
Key history and physical exam elementsCBC and CMP/LFT interpretationLipid panel and cardiovascular markersHormone profile, PSA, and gonadal testsECG, blood pressure, and ambulatory dataWhen to order echocardiogram or imaging
